Veru (VERU) Common Equity (2010 - 2026)
Veru (VERU) posted quarterly Common Equity of $34.8 million for Q1 2026, up 65.27% year-over-year from $21.0 million in Q1 2025, and down 6.3% quarter-over-quarter from $37.1 million in Q4 2025.
Veru (VERU) Common Equity (2010 - 2026) Analysis & Trends
Veru (VERU) has reported Common Equity for 17 consecutive years, with $34.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity rose 65.27% year-over-year to $34.8 million; the TTM figure through Mar 2026 stood at $34.8 million (up 65.27% YoY), while the FY2025 annual figure was $18.3 million, down 43.27% from the prior year.
- Common Equity retreated to $34.8 million in Q1 2026 per VERU's latest filing, from $37.1 million in the prior quarter.
- Across five years, Common Equity topped out at $136.0 million in Q1 2022 and bottomed at $15.3 million in Q2 2025.
- Historically, Common Equity has averaged $45.1 million across 5 years, with a median of $34.8 million in 2026.
- Annual changes were most pronounced in 2023 — Common Equity plunged 83.96% — and 2024, when it jumped 107.27%.
- Veru's Common Equity stood at $49.2 million in 2022, then rose by 4.9% to $51.6 million in 2023, then slumped by 48.4% to $26.6 million in 2024, then jumped by 39.42% to $37.1 million in 2025, then retreated by 6.3% to $34.8 million in 2026.
- Business Quant data shows VERU's Common Equity at $34.8 million in Q1 2026, $37.1 million in Q4 2025, and $18.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 1.35 Bn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | 22.38 Bn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 757.49 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 9.79 Bn |
| 10 | Veru | 61.54 Mn | 35.75 Mn | - | 28.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.38 Mn |
| Mar 31, 2026 | 34.79 Mn |
| Dec 31, 2025 | 37.12 Mn |
| Sep 30, 2025 | 18.33 Mn |
| Jun 30, 2025 | 15.34 Mn |
| Mar 31, 2025 | 21.05 Mn |
| Dec 31, 2024 | 26.63 Mn |
| Sep 30, 2024 | 32.32 Mn |
| Jun 30, 2024 | 37.62 Mn |
| Mar 31, 2024 | 45.21 Mn |
| Dec 31, 2023 | 51.60 Mn |
| Sep 30, 2023 | 19.68 Mn |
| Jun 30, 2023 | 20.65 Mn |
| Mar 31, 2023 | 21.81 Mn |
| Dec 31, 2022 | 49.19 Mn |
| Sep 30, 2022 | 82.80 Mn |
| Jun 30, 2022 | 116.87 Mn |
| Mar 31, 2022 | 136.00 Mn |
| Dec 31, 2021 | 148.00 Mn |
| Sep 30, 2021 | 154.52 Mn |